Finance
Oncology-focused biopharm company reports Q3 2005 revenues of $67.9 million
Published in Cancer Weekly, November 15th, 2005
For the third quarter of 2005, total revenues were $67.9 million compared to $55.6 million in the third quarter of 2004. Product sales increased to $66.4 million in the third quarter of 2005 from $54.9 million in the third quarter of 2004, primarily due to increased sales of Aloxi (palonosetron hydrochloride) injection. U.S. sales of Aloxi injection totaled $63.6 million, compared to $47.6 million in the third quarter of 2004.
Total costs and expenses decreased to $54.9 million in the third quarter of 2005...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-11-15)
More Articles from Cancer Weekly
- Apoptosis
Anti-apoptotic and malignancy-causing protein Mcl-1 inhibited mitochondrial Ca2+ signals - Cancer Risk Factors
Ovulation stress might cause ovarian cancer - Genetics & Genomics
Increased genomic instability leads to higher cancer incidence in elderly - Genotoxicity
Handling of antineoplastic drugs associated with genotoxic risks in oncology nurses - Tissue Preservation
Novel "tumor banking" method for freezing and storing research tissue specimens described - Adenocarcinomas
Incidence of adenocarcinoma was higher in young patients - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
